Stockpiling Biologics Under Hatch-Waxman Protection
A recent biosimilars litigation raises issues regarding the scope of the 35 U.S.C. ยง 271(e)(1) safe harbor provision and whether it protects commercial stockpiling. Amgen Inc. et al. v. Hospira Inc.,...To view the full article, register now.
Already a subscriber? Click here to view full article